Kodiak Sciences R&D Spending Growth & History (KOD)
Kodiak Sciences's r&d spending was $182.4M for fiscal 2025.
View full Kodiak Sciences company overviewKodiak Sciences annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $182.4M | $56.3M | +44.63% |
| 2024 | 2024-12-31 | $126.1M | −$80.2M | −38.88% |
| 2023 | 2023-12-31 | $206.3M | −$61.3M | −22.91% |
| 2022 | 2022-12-31 | $267.6M | $50.3M | +23.12% |
| 2021 | 2021-12-31 | $217.3M | $110.0M | +102.39% |
| 2020 | 2020-12-31 | $107.4M | $69.9M | +186.32% |
| 2019 | 2019-12-31 | $37.5M | $18.7M | +99.57% |
| 2018 | 2018-12-31 | $18.8M | −$3.2M | −14.66% |
| 2017 | 2017-12-31 | $22.0M | $8.0M | +56.71% |
| 2016 | 2016-12-31 | $14.1M | — | — |
Kodiak Sciences quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $56.1M | $13.3M | +31.16% |
| Q1 2026 | 2026-03-31 | $48.5M | $4.9M | +11.23% |
| Q4 2025 | 2025-12-31 | $45.5M | $13.7M | +43.19% |
| Q3 2025 | 2025-09-30 | $50.5M | $18.6M | +58.34% |
| Q2 2025 | 2025-06-30 | $42.8M | $10.2M | +31.51% |
| Q1 2025 | 2025-03-31 | $43.6M | $13.7M | +45.82% |
| Q4 2024 | 2024-12-31 | $31.8M | −$14.9M | −31.86% |
| Q3 2024 | 2024-09-30 | $31.9M | −$4.3M | −11.91% |
| Q2 2024 | 2024-06-30 | $32.5M | −$34.4M | −51.44% |
| Q1 2024 | 2024-03-31 | $29.9M | −$26.6M | −47.04% |
| Q4 2023 | 2023-12-31 | $46.6M | −$9.4M | −16.73% |
| Q3 2023 | 2023-09-30 | $36.2M | −$25.5M | −41.33% |
| Q2 2023 | 2023-06-30 | $67.0M | −$6.8M | −9.20% |
| Q1 2023 | 2023-03-31 | $56.5M | −$19.7M | −25.80% |
| Q4 2022 | 2022-12-31 | $56.0M | −$19.6M | −25.93% |
| Q3 2022 | 2022-09-30 | $61.7M | $5.7M | +10.13% |
| Q2 2022 | 2022-06-30 | $73.7M | $28.3M | +62.42% |
| Q1 2022 | 2022-03-31 | $76.2M | $35.8M | +88.85% |
| Q4 2021 | 2021-12-31 | $75.6M | $38.2M | +102.37% |
| Q3 2021 | 2021-09-30 | $56.0M | $26.7M | +91.09% |
| Q2 2021 | 2021-06-30 | $45.4M | $24.8M | +120.87% |
| Q1 2021 | 2021-03-31 | $40.3M | $20.2M | +99.99% |
| Q4 2020 | 2020-12-31 | $37.4M | $24.5M | +191.16% |
| Q3 2020 | 2020-09-30 | $29.3M | $19.2M | +189.73% |
| Q2 2020 | 2020-06-30 | $20.6M | $11.7M | +132.60% |
| Q1 2020 | 2020-03-31 | $20.2M | $14.4M | +252.44% |
| Q4 2019 | 2019-12-31 | $12.8M | $6.0M | +87.27% |
| Q3 2019 | 2019-09-30 | $10.1M | $5.4M | +114.80% |
| Q2 2019 | 2019-06-30 | $8.8M | $5.2M | +146.12% |
| Q1 2019 | 2019-03-31 | $5.7M | $2.1M | +57.14% |
| Q4 2018 | 2018-12-31 | $6.9M | — | — |
| Q3 2018 | 2018-09-30 | $4.7M | $1.6M | +49.59% |
| Q2 2018 | 2018-06-30 | $3.6M | — | — |
| Q1 2018 | 2018-03-31 | $3.6M | — | — |
| Q3 2017 | 2017-09-30 | $3.1M | — | — |
Kodiak Sciences r&d spending trends
Over the last five fiscal years, Kodiak Sciences's r&d spending increased from $107.4M to $182.4M, a change of $75.0M. The latest reported quarter, Q2 2026, shows $56.1M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kodiak Sciences source filings ↗